Search

everythinglearnresearchcommunity

for

Search:↓

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Genetic variants in CYP genes may worsen PCOS symptoms.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Both estrogens and androgens are important for health in both males and females.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Anti-androgens might help reduce COVID-19 severity in men.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.

Evaluate and manage androgen excess in women with a systematic approach, considering both physical and psychological impacts.

PCOS is managed with medication, lifestyle changes, and a healthy diet.

Removing both ovaries can treat increased testosterone and related symptoms in postmenopausal women with ovarian hyperthecosis.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

The 2004 hair research meeting presented new findings on hair cell differentiation, genetic factors in hair loss, hair pigmentation, and potential targeted therapies.

New treatment improves male hair loss.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Cell transplantation faces challenges in genitourinary reconstruction, but alternative tissue sources and microencapsulation show promise.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

The document concludes that personalized treatment, including lifestyle changes and medication, is essential for managing PCOS in teenagers, while also addressing their psychological well-being.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.